Evidence map›Paper›PMID 42050252›Full record

ReviewAnnals of surgical oncology2026

Mapping the Evidence for Surgical Care of Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP-NETs): A Scoping Review.

Léamarie Meloche-Dumas, Josh Bleicher, Kjetil Soreide, Els Nieveen van Djikum, Stefan Stättner, Lev Bubis, Alexandra Gangi, Stefano Partelli, Julie Hallet, CUTNETs collaborators

Abstract readScoping ReviewReview
PubMed Publisher
In one paragraph

Review in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Léamarie Meloche-DumasDepartment of Surgery, University of Toronto, Toronto, ON, Canada.
Josh BleicherDivision of Surgical Oncology, Yale University, New Haven, CT, USA.
Kjetil SoreideDepartment of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway.
Els Nieveen van DjikumGastroenterology Endocrinology Metabolism Cancer Center, Amsterdam UMC, Amsterdam, The Netherlands.
Stefan StättnerDepartment of General and Visceral Surgery, Hepatobiliary Centre, Kepler University Hospital GmbH, Linz, Austria.
Lev BubisDepartment of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada.
Alexandra GangiDepartment of Surgery, Cedars Sinai Medical Centre, Los Angeles, CA, USA.
Stefano PartelliSchool of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Julie HalletDepartment of Surgery, University of Toronto, Toronto, ON, Canada. Julie.hallet@sunnybrook.ca.
CUTNETs collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical management remains the cornerstone in the management of gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs), yet surgical indications and procedures are often inconsistent. To inform the development of a research agenda to strengthen the evidence in NETs surgical care, we conducted a scoping review to map the existing literature on surgery for gastro-entero-pancreatic (GEP) NETs. MATERIALS AND

methodsThe scoping review was conducted following the expanded framework of Arksey and O'Malley. A literature search was run on MEDLINE, Embase, and Scopus in October 2024 for studies published since 2000 reporting on any surgical intervention, performed under general or loco-regional anesthesia on adults with GEP-NETs at any stage.

resultsAmong the 10,000 studies screened, 260 were included. Publications included were mostly reviews covering a broad range of topics. Of the 120 original investigations, 96.7% were retrospective cohort studies and 43% were single center. There were only four prospective cohort studies. Of all publications included, the most common topics were observation of small pancreatic NETs, treatment of liver metastases, safety of minimally invasive surgery, and prognostication. Of original investigations, the majority compared surgical approaches, followed by examination of lymph node harvest and defining size cutoff for observation of pancreatic NETs.

conclusionsThis scoping review highlights limitations and gaps in the evidence supporting surgical care for GEP-NETs. Very few original investigations report prospective or multi-institutional data, and examination of pancreatic NETs dominate the literature. Future research should prioritize prospective, multi-institutional studies, stage- and primary-site-specific analyses, and interventional trials evaluating surgery relative to other therapies.

Indexed as

Intestinal NeoplasmsNeuroendocrine TumorsPancreatic NeoplasmsStomach NeoplasmsHumansPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.